Currently out of the existing stock ratings of Wangzhi Li, 23 are a BUY (92%), 2 are a HOLD (8%).

Wangzhi Li

Work Performance Price Targets & Ratings Chart

Analyst Wangzhi Li, carries an average stock price target met ratio of 65.63% that have a potential upside of 74.89% achieved within 411 days. Previously, Wangzhi Li worked at LADENBURG.

Wangzhi Li’s has documented 46 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on BGNE, BeiGene Ltd at 07-Dec-2020.

Wall Street Analyst Wangzhi Li

Analyst best performing recommendations are on ARCT (ARCTURUS THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for ARCT (ARCTURUS THERAPEUTICS HOLDINGS) at 3/4/2020. The price target of $28 was fulfilled within 54 days with a profit of $11.22 (66.87%) receiving and performance score of 12.38.

Average potential price target upside

of $680912 (68.09%) on APVO (APTEVO THERAPEUTICS).
of $38.98 (21.44%) on BGNE (BEIGENE LTD).
of $24.98 (140.77%) on KRYS (KRYSTAL BIOTECH).

BGNE BeiGene Ltd ARCT Arcturus Therapeutics Holdings BLCM Bellicum Pharmaceuticals CLLS Cellectis SA KRYS Krystal Biotech ALPN Alpine Immune Sciences APVO Aptevo Therapeutics FBRX Forte Biosciences

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Yaron Werber (TD COWEN)